NEW YORK (GenomeWeb) – Genome editing software company Desktop Genetics and Imperial College London's cancer epigenetics unit have received a £300,000 ($430,000) grant from Innovate UK, which they will use to develop software tools that selectively design CRISPR/Cas9 targets against cancer cell lines that are characterized at the epigenetic level.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.